Manufacturers Life Insurance Company, The Arvinas, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Arvinas, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 90,406 shares of ARVN stock, worth $1.64 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
90,406
Previous 95,105
4.94%
Holding current value
$1.64 Million
Previous $2.53 Million
12.05%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding ARVN
# of Institutions
231Shares Held
68.5MCall Options Held
226KPut Options Held
285K-
Vanguard Group Inc Valley Forge, PA7.01MShares$127 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$122 Million7.19% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$114 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.85MShares$69.9 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.78MShares$50.5 Million1.09% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $965M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...